Cargando…
RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY
INTRO: SARS-CoV-2 infection primarily affects the respiratory system. However, other organ systems may also be involved, leading to acute and chronic sequelae. Among other post-acute sequelae, incident diabetes is also being assessed but population-based evidence is still sparse. We evaluated the as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186874/ http://dx.doi.org/10.1016/j.ijid.2023.04.358 |
_version_ | 1785042639946514432 |
---|---|
author | Naveed, Z. García, H. Velásquez Wong, S. Wilton, J. McKee, G. Mahmood, B. Binka, M. Rasali, D. Janjua, N. |
author_facet | Naveed, Z. García, H. Velásquez Wong, S. Wilton, J. McKee, G. Mahmood, B. Binka, M. Rasali, D. Janjua, N. |
author_sort | Naveed, Z. |
collection | PubMed |
description | INTRO: SARS-CoV-2 infection primarily affects the respiratory system. However, other organ systems may also be involved, leading to acute and chronic sequelae. Among other post-acute sequelae, incident diabetes is also being assessed but population-based evidence is still sparse. We evaluated the association between COVID-19 infection including severity of infection and diabetes incidence using population-based registries and datasets. METHODS: We conducted a population-based matched retrospective cohort study using data from the BC COVID-19 Cohort. The exposure was SARS-CoV-2 infection, and the primary outcome was incident diabetes identified >30 days after the specimen collection-date for COVID-19 test. We performed multivariable Cox proportional hazard modeling to assess the effect of COVID-19 infection and disease severity on diabetes. Stratified analyses were performed to evaluate the effect modification of SARS-CoV-2 infection on diabetes risk. Finally, we computed, the confounder-adjusted population attributable fraction from the Cox models FINDINGS: During the median follow-up of 257 days, 608 (0.5%) events were observed among exposed and 1,864 (0.4%) among unexposed. Incident-diabetes rate/100,000 person-years was significantly higher among the exposed group vs. unexposed group (672.2 vs 508.7 respectively). The risk of incident diabetes was higher among those with COVID-19 infection (HR=1.16, 95% CI:1.06–1.28), and among males (aHR=1.22, 95%CI:1.06-1.40). The risk of diabetes was much higher among people with more severe disease (HRICU=3.32, 95%CI:1.99 – 5.54; HRhospitalized=1.97, 95%CI:1.33 – 2.93). CONCLUSION: SARS-CoV-2 infection is associated with higher risk of diabetes overall and among males. Severe SARS-CoV-2 infection is associated with higher risk of diabetes among both males and females. Furthermore, infection with SARS-CoV-2 could contribute to 3-5% increase in burden of diabetes, which will result in substantial number of diabetes cases with impact on healthcare needs for management of diabetes and its complications in addition to health of affected population. |
format | Online Article Text |
id | pubmed-10186874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101868742023-05-16 RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY Naveed, Z. García, H. Velásquez Wong, S. Wilton, J. McKee, G. Mahmood, B. Binka, M. Rasali, D. Janjua, N. Int J Infect Dis Article INTRO: SARS-CoV-2 infection primarily affects the respiratory system. However, other organ systems may also be involved, leading to acute and chronic sequelae. Among other post-acute sequelae, incident diabetes is also being assessed but population-based evidence is still sparse. We evaluated the association between COVID-19 infection including severity of infection and diabetes incidence using population-based registries and datasets. METHODS: We conducted a population-based matched retrospective cohort study using data from the BC COVID-19 Cohort. The exposure was SARS-CoV-2 infection, and the primary outcome was incident diabetes identified >30 days after the specimen collection-date for COVID-19 test. We performed multivariable Cox proportional hazard modeling to assess the effect of COVID-19 infection and disease severity on diabetes. Stratified analyses were performed to evaluate the effect modification of SARS-CoV-2 infection on diabetes risk. Finally, we computed, the confounder-adjusted population attributable fraction from the Cox models FINDINGS: During the median follow-up of 257 days, 608 (0.5%) events were observed among exposed and 1,864 (0.4%) among unexposed. Incident-diabetes rate/100,000 person-years was significantly higher among the exposed group vs. unexposed group (672.2 vs 508.7 respectively). The risk of incident diabetes was higher among those with COVID-19 infection (HR=1.16, 95% CI:1.06–1.28), and among males (aHR=1.22, 95%CI:1.06-1.40). The risk of diabetes was much higher among people with more severe disease (HRICU=3.32, 95%CI:1.99 – 5.54; HRhospitalized=1.97, 95%CI:1.33 – 2.93). CONCLUSION: SARS-CoV-2 infection is associated with higher risk of diabetes overall and among males. Severe SARS-CoV-2 infection is associated with higher risk of diabetes among both males and females. Furthermore, infection with SARS-CoV-2 could contribute to 3-5% increase in burden of diabetes, which will result in substantial number of diabetes cases with impact on healthcare needs for management of diabetes and its complications in addition to health of affected population. Published by Elsevier Ltd. 2023-05 2023-05-16 /pmc/articles/PMC10186874/ http://dx.doi.org/10.1016/j.ijid.2023.04.358 Text en Copyright © 2023 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Naveed, Z. García, H. Velásquez Wong, S. Wilton, J. McKee, G. Mahmood, B. Binka, M. Rasali, D. Janjua, N. RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title | RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title_full | RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title_fullStr | RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title_full_unstemmed | RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title_short | RISK OF INCIDENT DIABETES FOLLOWING COVID-19 INFECTION: A POPULATION-BASED COHORT STUDY |
title_sort | risk of incident diabetes following covid-19 infection: a population-based cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186874/ http://dx.doi.org/10.1016/j.ijid.2023.04.358 |
work_keys_str_mv | AT naveedz riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT garciahvelasquez riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT wongs riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT wiltonj riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT mckeeg riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT mahmoodb riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT binkam riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT rasalid riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy AT janjuan riskofincidentdiabetesfollowingcovid19infectionapopulationbasedcohortstudy |